Heidelberg Engineering Supports “Glaucoma / Myopia OCT Phenotyping Consortium”

Heidelberg Engineering is serving as a member of the Glaucoma / Myopia OCT Phenotyping Consortium (GMOPC), in a new effort to support research to improve the detection of glaucoma, the world´s leading cause of irreversible vision loss. The GMOPC was established in February 2020 at an inaugural meeting in Los Angeles, California, as an investigator-initiated clinical research study, with Heidelberg Engineering as an industry partner. The consortium comprises 13 clinical centers in seven countries and provides a new research platform for acquiring OCT images, data storage and retrieval for efficient review, quality control and secure access. Looking beyond established risk ...